Innovative strength has been a cornerstone of Bachem’s business success since the founding nearly 50 years ago. Günther Loidl, Chief Technology Officer for Bachem Holding...
19.09.2018
- Natural products have been used since thousands of years for the treatment of a wide range of medical conditions in the form of traditional medicines. Today 60% of all new small...
Swiss biochemicals company Bachem announced that Dr. Anne-Kathrin Stoller will succeed Dr. José de Chastonay as Chief Marketing Officer of the organization on January 1...
13.04.2017
- US drugmaker Janssen Pharmaceuticals has entered into a collaboration with Japanese biopharma PeptiDream. The deal, which gives Janssen access to PeptiDream’s peptide discovery...
08.12.2016
- Swiss specialty chemicals and biologics producer Lonza has agreed to sell its peptides business and operations in Braine-l’Alleud, Belgium, to PolyPeptide Laboratories Holding (PPL...
05.12.2016
- Anglo-Swedish drugmaker AstraZeneca is collaborating with Bicycle Therapeutics to develop a novel class of small-molecule medicines for treating respiratory, cardiovascular and...
26.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
08.09.2016
- Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...
